NL

Nick Lydon

North America, Massachusetts, United States, Cambridge

Description

Nick Lydon is the Scientific Founder of Blueprint Medicines. He previously worked at Ambit Biosciences Corp as a scientific advisor and memb...

Investor Profile

Nick Lydon has backed more than 1 startups, with 1 new investments in the last 12 months alone. The firm has led 0 rounds, about 0% of its total and boasts 0 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series B rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Life Science, Oncology.

Stage Focus

  • Series B (100%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Life Science
  • Oncology
  • Product Research
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Nick Lydon frequently co-invest with?

Nextech Invest
Europe, Zurich, Switzerland, Zürich
Co-Investments: 1
Casdin Capital
North America, New York, United States, New York
Co-Investments: 1
Co-Investments: 1
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 1
Merck KGaA, Darmstadt, Germany
Europe, Hessen, Germany, Darmstadt
Co-Investments: 1
Andreessen Horowitz
North America, California, United States, Menlo Park
Co-Investments: 1
CC
North America, New York, United States, New York
Co-Investments: 1
Blackstone Group
North America, New York, United States, New York
Co-Investments: 1

What are some of recent deals done by Nick Lydon?

Idrx

Plymouth, Massachusetts, United States

Idrx is a clinical-stage biopharmaceutical company dedicated to transforming cancer treatment.

BiotechnologyLife ScienceOncologyProduct Research
Series BAug 7, 2024
Amount Raised: $120,000,000